Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Novel diagnostic assays for heparin-induced thrombocytopenia | Blood Journal |
| 33 | 2013 |
FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Journal of Thrombosis and Haemostasis | 11 | 2013 | |
Is the Incidence of Heparin-Induced Thrombocytopenia Affected by the Increased Use of Heparin for VTE Prophylaxis? | CHEST |
| 8 | 2012 |
Incidence of Thrombocytopenia among Patients Receiving Heparin Venous Thromboembolism Prophylaxis | The American Journal of Medicine |
| 8 | 2012 |
Thrombosis in Suspected Heparin-induced Thrombocytopenia Occurs More Often with High Antibody Levels | The American Journal of Medicine |
| 40 | 2012 |
Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Being precise with anticoagulation to reduce adverse drug reactions: are we there yet? | The Pharmacogenomics Journal |
| 2024 | |
Unresponsiveness of Activated Partial Thromboplastin Time to Bivalirudin in Adults Receiving Extracorporeal Membrane Oxygenation | ASAIO Journal |
| 2024 | |
Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura | Biomedicines |
| 2024 | |
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink | Blood Reviews |
| 2 | 2023 |
Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases | Expert Review of Hematology |
| 2023 |